3BIGS, YZone and Women’s YZONE Healthcare research and business collaboration

3BIGS CEO Park Jun-hyung (left) and WHY ZONE CEO Park Young-im are taking a commemorative photo. [Photo = 3BIGS]

[Seoul = Newspim] Reporter Lee Na-young :

3BIGS, a company specializing in new drug development based on bio big data announced on the 28th that it signed a business agreement with WHY ZONE, a company specializing in women’s WHY ZONE health, for research and commercialization of women’s WHY ZONE healthcare.

The main goal of this agreement is to develop a simple health care service for women that combines 3BIGS’ self-developed human microbiome big data platform and WHY ZONE’s healthcare technology.

“Bio big data can enter various business areas depending on the collection method and direction of use,” said Park Junhyung, CEO of 3BIGS. “Based on our professional microbiome database and technology, we will provide accurate health information to female consumers around the world.” “We will do our best to commercialize the technology.” WHY ZONE CEO Park Young-im said, “We will prove the positive effects of our products on women’s WHY ZONE through vaginal microbiome testing,” adding, “We will provide high-quality customized services to respond to the segmented women’s health care target group.” “I will do my best,” he said.